Global S&T Development Trend Analysis Platform of Resources and Environment
UK government commits over £30 million of funding to tackle antimicrobial resistance | |
admin | |
2018-05-24 | |
发布年 | 2018 |
语种 | 英语 |
国家 | 英国 |
领域 | 资源环境 |
正文(英文) | The UK government has announced that it will be committing over £30 million of funding and will continue to lead the global fight against antimicrobial resistance. The funding will be delivered via four new projects as part of the Global AMR Innovation Fund (GAMRIF). Antimicrobial resistance (AMR) happens when microbes including bacteria, viruses, fungi and parasites no longer respond to the drugs (including antibiotics) which would normally kill them. This leaves us powerless to treat what are normally routine infections. The UK government's Global AMR Innovation Fund is providing seed funding for innovative research and development to tackle the growing threat of AMR globally. This funding will be targeted in low and middle income countries (LMICs) where the burden is greatest and is crucial for the health and economic prosperity of the world's poorest. The new projects are:
These projects are funded by UK aid and will primarily benefit people in low and middle income countries, where the burden of infection is greatest. Professor Dame Sally Davies, England's Chief Medical Officer, said:
Health & Social Care Secretary Jeremy Hunt said:
GAMRIF's other projects include:
It is estimated that 5,000 deaths are caused every year in the UK because antibiotics no longer work for some infections. Lord Jim O'Neill's UK review on AMR in 2016 estimated that by 2050, if no actions are taken to contain AMR, the number of deaths could rise to 10 million by 2050 and cost the global economy up to US $100 trillion. Rising drug resistance is a threat that knows no borders, if we do not tackle it, every day procedures such as caesareans sections, cancer therapy, and hip replacements will become extremely dangerous. Further informationJo Thompson Notes1. The Department for Health & Social Care (DHSC) is the UK government department which is responsible for helping people to live more independent, healthier lives for longer. The Global Antimicrobial Innovation Fund was established to provide seed funding for innovative research and development, specifically in neglected and underinvested areas, to address the threat of AMR. GAMRIF is a £50 million official development assistance (ODA) investment, which means all projects funded must meet ODA-eligibility requirements, and support research primarily and directly for the benefit of people in low and middle income countries. The fund takes a 'One Health' approach, seeking to invest in potential solutions to reduce the threat of AMR in humans, animals, fish and the environment. The fund seeks to leverage additional global funding through interaction with international government bodies, public-private partnerships, product development partnerships, global funding mechanisms and global forums. |
URL | 查看原文 |
来源平台 | Natural Environment Research Council |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/103728 |
专题 | 资源环境科学 |
推荐引用方式 GB/T 7714 | admin. UK government commits over £30 million of funding to tackle antimicrobial resistance. 2018. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论